DICE Therapeutics, Inc. Profile Avatar - Palmy Investing

DICE Therapeutics, Inc.

DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulat…
Biotechnology
US, South San Francisco [HQ]

Balance Sheet

4 Sheets · Starting from 2022
In Million USD. Margins, Growth Rates In %
Metric 2019 2020 2021 2022
Assets
31.00 63.00 325.00 593.00
Current
29.00 62.00 323.00 577.00
Non Current
2.00 1.00 1.00 16.00
Liabilities
60.00 117.00 12.00 26.00
Current
3.00 9.00 10.00 15.00
Non Current
57.00 107.00 1.00 11.00
Equity
-29.00 -53.00 -103.00 -187.00
Stockholders' Equity
-29.00 -53.00 -103.00 -187.00
Retained Earnings
-31.00 -54.00 -103.00 -187.00
Common Stock
- - - - - - - -
Preferred Stock
- - - - 325.00 - -
Profit
-12.00 -23.00 -48.00 -81.00
Dividends
- - - - - - - -
Minority Interest
- - - - - - - -
Other Stockholders' Equity
1.00 1.00 -325.00 - -
Loss Other Compr. Income
- - - - - - - -
End of DICE's Analysis
CIK: 1645569 CUSIP: 23345J104 ISIN: US23345J1043 LEI: - UEI: -
Secondary Listings
DICE has no secondary listings inside our databases.